| OR THE PERIOD 2u April | 2022to 31"March | 2023 | 2023 | ||
|---|---|---|---|---|---|
| Unrestricted | Endowment | Totalf | Total f | ||
| Funds f2023 | Funds f | 2023 | 2023 | 2022 | |
| Income From: | |||||
| Dividends and interest |
30,252 | 30,252 | 28,130 | ||
| Uncashed cheques | 742 | 742 | |||
| written off | |||||
| Disposal proceeds on | 84,260 | 84,260 | 153,917 | ||
| investment sales |
|||||
| Total Income | 30,994 | 84p260 | 115,254 | 182,047 | |
| Expenditure On: |
|||||
| Charitable Activities |
(198) | (198) | (1,336) | ||
| Support costs | (2,600) | (8,113) | (10,713) | (8,379) | |
| Investment purchases |
(55,183) | (55,183) | (146,872) | ||
| Gain/(loss) on |
(89,781) | (89,781) | 52,872 | ||
| investment | |||||
| Movement on grant |
(15,036) | (15,036) | (33,771) | ||
| commitments | |||||
| Tote Iresources | (17,834) | (153,077) | (170,911) | (137,486) | |
| expended | |||||
| Net | 13,160 | (68,817) | (55,657) | 44,561 | |
| (outgoing)/incoming | |||||
| resources | |||||
| Net movement in |
13,160 | (68,817) | (55,657) | 44,561 | |
| funds | |||||
| Fund balances at 1" | 100,208 | 877,064 | 977,272 | 932,711 | |
| April 2022 | |||||
| Fund balances at 31u | 113,368 | 808,247 | 921,615 | 977,272 | |
| March 2023 |
| 2023 | 2022 | |||
|---|---|---|---|---|
| Notes | ||||
| Investments | ||||
| Quoted securities | 778,790 | 868,571 | ||
| Current assets | ||||
| Debtors | 6,591 | 6,589 | ||
| Cash at bank and in | 243,897 | 195,496 | ||
| hand | ||||
| Creditors; amounts | (107,663) | (93,384) | ||
| falling due within one | ||||
| year | ||||
| Net current assets | 921&615 | 977,272 | ||
| Income funds | ||||
| Endowment funds |
808,247 | 877,064 | ||
| Unrestricted funds |
113,367 | 100,208 | ||
| 921,615 | ~ | 977,272 |
| Unrestricted | Endowment | Total | Total 2022 | ||||
|---|---|---|---|---|---|---|---|
| funds | funds | 2023 | |||||
| Dividends | 28,695 | 28,695 | 28,068 | ||||
| Interest | 1,557 | 1,557 | 62 | ||||
| Uncashed | che | ues written | off | 742 | 742 | ||
| Disposal proceeds on investment sales |
84,260 | 84,260 | 153,917 | ||||
| Totals | 30,994 | 84&260 | 115,254 | 182,047 | |||
| 4. Charitable |
activities | ||||||
| Unrestricted | Endowment | Total | Total 2022 | ||||
| funds | funds | 2023 | |||||
| GGtG | fah | ||||||
| Project SF118 | 198 | 198 | 807 | ||||
| Project SF127 | 529 | ||||||
| Totals | 198 | 198 | 1,336 |
| Unrestricted | Endowment | Total | Total 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| funds | funds | 2023 | ||||||
| Trustee indemnity | insurance | 448 | 448 | 463 | ||||
| Investment | management | fees | 8,113 | 8,113 | 6,116 | |||
| Accountanc | fees | 1,800 | 1,800 | 1,800 | ||||
| Other support | costs | 352 | 352 | |||||
| Totals | 2,600 | 8,113 | 10,713 | 8,379 |
| 6. Investments |
|
|---|---|
| Quoted securities | |
| investment portfolio b/f |
868,571 |
| Investment gains/(losses) |
(89,781 |
| Investment portfolio c/f |
778,790 |
| Total Investment 2023 |
778,790 |
| Total Investment 2022 |
868,571 |
| 2023 E | 20226 | ||
|---|---|---|---|
| Accrued | interest | 322 | 100 |
| Accrued | Income | 6,269 | 6,489 |
| Totals | 6,591 | 6,589 |
| 2023 E | 2022 6 | ||
|---|---|---|---|
| Accruals | 1,800 | 1,800 | |
| Other creditors | 448 | 1,205 | |
| Grant commitments | (note 9 | 105,415 | 90,379 |
| Totals | 107,663 | 93,384 |
| Balance | Grants | Grants paid | Grants | Balance at | |||
|---|---|---|---|---|---|---|---|
| at 1Apr | made | cancelled | 31Mar | ||||
| 2022 | 2023 | ||||||
| SF118 | 5,115 | (198 | 4,917 | ||||
| SF123 | 9,644 | (9,644) | |||||
| SF124 | 2,114 | (2,114) | |||||
| SF125 | 9,303 | 9,303 | |||||
| SF127 | 9,471 | 9,471 | |||||
| SF128 | 14,932 | (14,932) | |||||
| SF129 | 9,865 | 9,865 | |||||
| SF130 | 14,935 | 14,935 | |||||
| SF131 | 15,000 | 15,000 | |||||
| SF133 | 12,624 | 12,624 | |||||
| SF134 | 14,600 | 14,600 | |||||
| SF135 | 14,700 | 14,700 | |||||
| Total | 90,379 | 41,924 | (2,312) | (24,576) | 105,415 | ||
| SF118- The | clinicalutility | ofexome sequencing | approaches | and the functional | evaluation | ofpossible | |
| pathogenic | variants - Maggie Williams |
| Investment | ortfolio b/f | 868,571 |
|---|---|---|
| Investment | gains/(losses) | (89,781) |
| Investment | portfolio c/f | 778,790 |
| Investment | cash account b/f | 8,493 |
| Investment | disposals | 84,260 |
| Investment | purchases | (55,183) |
| Investment | management fees |
(8,113) |
| Investment | cash account c/f | 29,457 |
| Total Endowment fund 2023 |
808,247 | |
| Total Endowment fund 2022 |
877,064 |